ISRCTN ISRCTN16665940
DOI https://doi.org/10.1186/ISRCTN16665940
Secondary identifying numbers SSCC012
Submission date
12/02/2018
Registration date
20/02/2018
Last edited
21/12/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
The term sarcopenia means the loss of muscle mass and muscle function with age, especially among elderly people. Previous studies have shown that improving vitamin D status among the elderly may lead to an improvement in muscle mass and muscle strength. The aim of this study is to examine the effect of vitamin D supplementation on muscle mass and strength in sarcopenic older Lebanese people.

Who can participate?
Adults aged 71-77 who are deficient in vitamin D.

What does the study involve?
Participants are randomly allocated to one of two groups. Those in the first group receive vitamin D supplments. Those in the second group receive a dummy supplement. Participants take the supplement for six months. Participants are followed up to assess strength and functional assessment and biochemical analysis after six months to see if they have improved.

What are the possible benefits and risks of participating?
Participants may benefit from vitamin D supplementation as it may improve muscle strength and sarcopenia. No risks are involved in the participants taking part in the study.

Where is the study run from?
Hopital Saint Charles (Lebanon)

When is the study starting and how long is it expected to run for?
August 2014 to December 2015

Who is funding the study?
Saint Charles Hospital (Lebanon)

Who is the main contact?
Miss El Hajj Cynthia (Scientific)
cynthiaeliashajj102@gmail.com

Contact information

Miss El Hajj Cynthia
Scientific

Universite d’Auvergne
49 Boulevard François Mitterrand
Clermont-Ferrand
63000
France

Phone +33 4 73 60 82 76
Email cynthiaeliashajj102@gmail.com

Study information

Study designRandomided controlled double blind study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleVitamin D supplementation and muscle strength in sarcopenic elderly Lebanese people: A randomised controlled trial
Study objectivesVitamin D supplementation has beneficial effects on muscle strength and muscle mass in elderly.
Ethics approval(s)Ethics Committee Institutional Review Board Saint Charles Hospital, 11/02/2015, ref: SSCC012
Health condition(s) or problem(s) studiedSarcopenia and Vitamin D Deficiency
InterventionIn this randomized, controlled, double blind study, participants are randomized (using the simple randomization method) to receive either a supplement of 10,000 IU of cholecalciferol (Euro-Pharm International, Canada) or a placebo tablet (containing microcrystalline cellulose: 66.3%, starch: 33.2%, magnesium stearate: 0.5%, per serving ) to be taken three times per week for a period of six months.

The participants are seen after six months of supplementation with vitamin D or placebo, and followed up by phone calls at three months.
Intervention typeSupplement
Primary outcome measure1. Handgrip strength is measured using the Martin vigorimeter (Martin; Elmed, Addison, IL, USA), at baseline and 6 months.
2. Appendicular skeletal muscle mass is measured using bioimpedance analysis measurements (Tanita BC-418 Segmental Body Composition Analyzer, Illinois, USA) at baseline and 6 months.
3. 25 (OH)D levels are measured using radioimmunoassay (DiaSorin, Stillwater, MN) at baseline and 6 months
Secondary outcome measures1. Weight is measured using the body composition analyzer (Tanita BC-418 Segmental Body Composition Analyzer, Illinois, USA) at baseline and 6 months
2. BMI is calculated using the standard formula (body weight in kilograms divided by square of body height in meters). at baseline and 6 months
3. Waist circumference is measured at the iliac crest at baseline and 6 months
4. Fat Mass is measured using the body composition analyzer (Tanita BC-418 Segmental Body Composition Analyzer, Illinois, USA) at baseline and 6 months
5. PTH is measured using a two-site immunoradiometric assay with an NH2-terminal monoclonal antibody as capture (Fitzgerald Industries International Inc., USA), at baseline and 6 months
6. Serum creatinine is measured using the Jaffe kineticalkaline picrate reaction (Interpretation and Techniques, Lea and Febiger, Philadelphia), at baseline and 6 months
Overall study start date02/08/2014
Completion date04/12/2015

Eligibility

Participant type(s)Healthy volunteer
Age groupSenior
SexBoth
Target number of participants115
Key inclusion criteria1. Sarcopenic
2. Deficient in vitamin D
3. No medical history of type-2 diabetes
4. Age range of participants: 71-77
Key exclusion criteria1. Sarcopenic subjects
2. Incidence of balance problems due to neurological disorders
3. Renal failure
4. Congestive heart failure and acute heart insufficiency as well as uncontrolled arterial hypertension or hypotension
5. Use of sedative (that could affect balance)
6. Use of vitamin D supplementation
7. Primary hyperparathyroidism
Date of first enrolment02/07/2015
Date of final enrolment19/09/2015

Locations

Countries of recruitment

  • Lebanon

Study participating centre

Hopital Saint Charles
Fiyadiyeh- Baabda
Beirut
50
Lebanon

Sponsor information

Universite d’Auvergne
Other

Funders

Funder type

Not defined

Saint Charles Hospital

No information available

Results and Publications

Intention to publish date02/04/2018
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication. Study protocol, statistical analysis plan, and others are available.
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Cynthia El Hajj
Email address: cynthiaeliashajj102@gmail.com

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 19/12/2018 Yes No

Editorial Notes

21/12/2018: Publication reference added.